Related Experiment Video
Updated: Jul 13, 2026

Isolation and Differentiation of Adipose-Derived Stem Cells from Porcine Subcutaneous Adipose Tissues
Published on: March 31, 2016
20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells
Woo-Kyun Kim1, Vicente Meliton, Christopher M Amantea
1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Unlabelled:
Specific oxysterols have been shown to be pro-osteogenic and anti-adipogenic. However, the molecular mechanism(s) by which oxysterols inhibit adipogenic differentiation is unknown. We show that the anti-adipogenic effects of osteogenic oxysterol, 20(S)-hydroxycholesterol, are mediated through a hedgehog-dependent mechanism(s) and are associated with inhibition of PPARgamma expression.
Introduction:
Multipotent bone marrow stromal cells (MSCs) are common progenitors of osteoblasts and adipocytes. A reciprocal relationship between osteogenic and adipogenic differentiation may explain the increased adipocyte and decreased osteoblast formation in aging and osteoporosis. We have previously reported that specific oxysterols stimulate osteogenic differentiation of MSCs while inhibiting their adipogenic differentiation.
Materials And Methods:
The M2-10B4 (M2) murine pluripotent bone MSC line was used to assess the inhibitory effects of 20(S)-hydroxycholesterol (20S) and sonic hedgehog (Shh) on peroxisome proliferator-activated receptor gamma (PPARgamma) and adipogenic differentiation. All results were analyzed for statistical significance using ANOVA.
Results And Conclusions:
Treatment of M2 cells with the osteogenic oxysterol 20S completely inhibited adipocyte formation induced by troglitazone after 10 days. PPARgamma mRNA expression assessed by RT-qPCR was significantly induced by Tro after 48 (5-fold) and 96 h (130-fold), and this induction was completely inhibited by 20S. In contrast, 20S did not inhibit PPARgamma transcriptional activity in M2 cells overexpressing PPARgamma and retinoid X receptor (RXR). To elucidate the molecular mechanism(s) by which 20S inhibits PPARgamma expression and adipogenic differentiation, we focused on the hedgehog signaling pathway, which we previously showed to be the mediator of osteogenic responses to oxysterols. The hedgehog signaling inhibitor, cyclopamine, reversed the inhibitory effects of 20S and Shh on troglitazone-induced adipocyte formation in 10-day cultures of M2 cells by 70% and 100%, respectively, and the inhibitory effect of 20S and Shh on troglitazone-induced PPARgamma expression was fully reversed at 48 h by cyclopamine. Furthermore, 20S and Shh greatly inhibited PPARgamma2 promoter activity induced by CCAAT/enhancer-binding protein alpha overexpression. These studies show that, similar to the induction of osteogenesis, the inhibition of adipogenesis in murine MSCs by the osteogenic oxysterol, 20S, is mediated through a hedgehog-dependent mechanism(s).
Insights
The osteogenic oxysterol 20(S)-hydroxycholesterol inhibits adipocyte differentiation by suppressing PPARgamma expression through a hedgehog-dependent pathway. This finding offers insights into bone marrow stromal cell differentiation and potential therapeutic targets for osteoporosis.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Multipotent bone marrow stromal cells (MSCs) differentiate into osteoblasts and adipocytes.
- Reciprocal differentiation of MSCs influences bone and fat formation, particularly in aging and osteoporosis.
- Specific oxysterols, including 20(S)-hydroxycholesterol, have demonstrated pro-osteogenic and anti-adipogenic properties.
Purpose of the Study:
- To investigate the molecular mechanisms by which oxysterols inhibit adipogenic differentiation.
- To determine if the hedgehog signaling pathway mediates the anti-adipogenic effects of 20(S)-hydroxycholesterol.
- To assess the impact of 20(S)-hydroxycholesterol on peroxisome proliferator-activated receptor gamma (PPARgamma) expression during adipogenesis.
Main Methods:
- Utilized the M2-10B4 murine MSC line.
- Assessed the effects of 20(S)-hydroxycholesterol and sonic hedgehog (Shh) on adipogenic differentiation and PPARgamma expression.
- Employed RT-qPCR, promoter activity assays, and statistical analysis (ANOVA).
Main Results:
- 20(S)-hydroxycholesterol completely inhibited troglitazone-induced adipocyte formation and PPARgamma mRNA induction in MSCs.
- The inhibitory effects of 20(S)-hydroxycholesterol on adipogenesis and PPARgamma expression were reversed by the hedgehog signaling inhibitor cyclopamine.
- 20(S)-hydroxycholesterol and Shh suppressed PPARgamma2 promoter activity, indicating regulation at the transcriptional level.
Conclusions:
- The anti-adipogenic effects of 20(S)-hydroxycholesterol in murine MSCs are mediated by a hedgehog-dependent mechanism.
- Inhibition of PPARgamma expression is a key factor in the anti-adipogenic action of this oxysterol.
- These findings elucidate the molecular pathways involved in oxysterol-mediated regulation of MSC differentiation, relevant to bone health and metabolic disorders.
Related Concept Videos
Hedgehog Signaling Pathway
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cell Specific Gene Expression
TGF - β Signaling Pathway

